Local Institution - 141

Kirkland, Washington 98034

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063) — Stopped early
• A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis — Completed